A phase III study to investigate a vaccine against COVID-19

Summary

A phase III study to investigate a vaccine against COVID-19 is a clinical trial^[1].

Key Facts

• A phase III study to investigate a vaccine against COVID-19 is in the country of Brazil^[2].
• A phase III study to investigate a vaccine against COVID-19's instance of is recorded as clinical trial^[3].
• A phase III study to investigate a vaccine against COVID-19's DOI is recorded as 10.1186/ISRCTN89951424^[4].
• A phase III study to investigate a vaccine against COVID-19's publication date is recorded as +2020-06-11T00:00:00Z^[5].
• A phase III study to investigate a vaccine against COVID-19's start time is recorded as +2020-05-01T00:00:00Z^[6].
• A phase III study to investigate a vaccine against COVID-19's end time is recorded as +2021-10-31T00:00:00Z^[7].
• A phase III study to investigate a vaccine against COVID-19's main subject is recorded as AZD1222^[8].
• A phase III study to investigate a vaccine against COVID-19's main subject is recorded as COVID-19^[9].
• A phase III study to investigate a vaccine against COVID-19's number of participants is recorded as {'unit': '1', 'amount': '+2000'}^[10].
• A phase III study to investigate a vaccine against COVID-19's title is recorded as A phase III randomized controlled trial to determine safety, efficacy, and immunogenicity of the non-replicating ChAdOx1 nCoV-19 vaccine^[11].
• A phase III study to investigate a vaccine against COVID-19's author name string is recorded as Peter O'Reilly^[12].
• A phase III study to investigate a vaccine against COVID-19's clinical trial phase is recorded as phase III clinical trial^[13].